文献速递临床生化临床免疫质量管理与危急值

欧洲临床实验室男性雄激素检测与报告调查

A survey on measurement and reporting of total testosterone, sex hormone-binding globulin and free testosterone in clinical laboratories in Europe.
PubMed 文献 · Clin Chem Lab Med · 2025-03-12

该调查于2022年12月至2023年12月通过互联网发放,分析27个欧洲国家临床实验室的124份记录,比较男性总睾酮、性激素结合球蛋白和游离睾酮的检测流程。结果显示总睾酮检测以自动化平台酶联免疫分析为主,仅四分之一中心使用质谱,游离睾酮多采用Vermeulen公式计算,参考范围上下限报告差异大,且对晨间采样和空腹采样等分析前要求依从性不足。

要点

  • 总睾酮检测以自动化平台酶联免疫分析为主,仅四分之一中心使用质谱。
  • 游离睾酮多通过Vermeulen公式计算获得,SHBG全部采用免疫分析检测。
  • 总睾酮、SHBG和计算游离睾酮参考范围上下限报告差异大,结果难以跨中心比较。

核心结论

  • 欧洲临床实验室男性雄激素评估存在显著的实验室间差异,提示不同中心临床检测结果不可互换。
  • 分析前建议的依从性较差,需继续推动SHBG和总/游离睾酮检测程序的标准化。

研究设计与样本

  • 2022年12月至2023年12月通过临床实验室/化学和内分泌学会发放的互联网调查。
  • 分析来自27个欧洲国家临床实验室的124份唯一记录。

主要发现

  • 总睾酮主要采用自动化平台上的酶联免疫分析定量,仅四分之一中心使用质谱。
  • SHBG仅通过免疫分析检测。
  • 游离睾酮被多数临床实验室使用,主要报告为采用Vermeulen公式计算游离睾酮的近似值。
  • 总睾酮、SHBG和计算游离睾酮的参考范围通常按年龄分层报告,但报告的上下限存在明显差异。
  • 不足半数临床实验室推荐充分的晨间采样时间和/或空腹采样。

关键数值与推荐

  • 总睾酮检测中仅四分之一中心使用质谱,其余主要采用自动化平台酶联免疫分析。
  • SHBG全部采用免疫分析检测。
  • 游离睾酮主要报告为采用Vermeulen公式计算游离睾酮的近似值。
  • 总睾酮、SHBG和计算游离睾酮的参考范围通常按年龄分层,但报告的上下限存在明显差异。

临床怎么用

  • 解读雄激素检测结果时应使用检测方法特异性参考范围,避免跨实验室直接比较。
  • 应关注并改进总睾酮检测的分析前要求,如晨间采样和空腹采样。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To compare clinical laboratory workflows for the assessment of androgens in men, focusing on total testosterone (T), sex hormone-binding globulin (SHBG) and free T, in clinical laboratories throughout Europe. METHODS: An internet-based survey that included questions related to pre-analytical, analytical and post-analytical phases of androgen measurements was distributed between December 2022 and December 2023 by clinical laboratory/chemistry and endocrine societies. A total of 124 unique records from clinical laboratories in 27 European countries were analyzed. RESULTS: Pre-analytical requirements for total T are subject to improvement as less than half of clinical laboratories recommended adequate morning sampling time and/or sampling in a fasting state. Total T was predominantly quantified using enzyme-linked immunoassay (IA) on automated platforms, with only one in four centers using mass spectrometry (MS), while SHBG was exclusively measured by IA. Additionally, free T was used by a majority of clinical laboratories, mainly reported as approximation by calculation of free T (cFT) using the Vermeulen formula. Generally, age-stratification was the preferred means of reporting reference ranges for total T, SHBG and cFT. However, considerate variability was observed in reported lower and upper limits, leading to the necessity of interpreting test results against assay-specific reference ranges, thereby hindering comparability of results between clinical laboratories. CONCLUSIONS: Our survey highlights significant inter-laboratory variability for the assessment of androgen status in men, implying non-commutability of clinical test results between different centers. In addition, we observed poor adherence to pre-analytical recommendations. These findings advocate for continued harmonization efforts of measurement procedures for SHBG and total/free T.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Narinx N, Nyamaah JA, David K, et al. A survey on measurement and reporting of total testosterone, sex hormone-binding globulin and free testosterone in clinical laboratories in Europe. Clin Chem Lab Med. 2025. PMID: 40068942. doi:10.1515/cclm-2024-1237

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。